# Acute Effects of Inhaled Treprostinil in Fontan Patients

> **NCT02769624** · PHASE2 · TERMINATED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 15 (actual)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **DRUG:** Treprostinil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02769624
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-21
- **Primary completion:** 2018-09-21
- **Final completion:** 2018-09-21
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Study was stopped early due to inability to recruit additional participants
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02769624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02769624, "Acute Effects of Inhaled Treprostinil in Fontan Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02769624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*